Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) enhances tau expression

Journal of Alzheimer's Disease

Volumn 37, Issue 3, 2013, Pages 529-538

  Qian, Wei ^a,b   Jin, Nana ^a,c   Shi, Jianhua ^b   Yin, Xiaomin ^b   Jin, Xiaoxia ^a   Wang, Shibao ^a   Cao, Maohong ^a   Iqbal, Khalid ^c   Gong, Cheng Xin ^a,c   Liu, Fei ^a,c  

^a NANTONG UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Down syndrome; Dyrk1A; mRNA stability; tau

Indexed keywords

DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1A; MESSENGER RNA; PROTEIN TYROSINE KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHROMOSOME 16; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; EXON; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARTIAL TRISOMY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; RNA SYNTHESIS; WESTERN BLOTTING;

ANIMALS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RATS; RNA, MESSENGER; TAU PROTEINS;

EID: 84892720147     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130824     Document Type: Article

References (38)

1. Kar S, Fan J, Smith MJ, Goedert M, Amos LA (2003) Repeat motifsoftau bindto the insides of microtubulesin the absence of taxol. EMBO J 22, 70-77.
2. Schoenfeld TA, Obar RA (1994) Diverse distribution and function offibrous microtubule-associated proteinsin the nervous system. Int Rev Cytol 151, 67-137.
3. Mandelkow E, Mandelkow EM (1995) Microtubules and microtubule-associated proteins. Curr Opin Cell Biol 7, 72-81.
4. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672.
5. Hernandez F, Avila J (2007) Tauopathies. Cell Mol Life Sci 64, 2219-2233.
6. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wis-niewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
7. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089.
8. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351, 80-84.
9. Oyama F, Cairns NJ, Shimada H, Oyama R, Titani K, Ihara Y (1994) Down's syndrome: Up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62, 1062-1066.
10. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxic-ity. Proc Natl Acad Sci USA 99, 6364-6369.
11. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 108, 5819-5824.
12. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
13. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397.
14. Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA (1986) Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 387, 271-280.
15. Andreadis A, Broderick JA, Kosik KS (1995) Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. Nucleic Acids Res 23, 3585-3593.
16. Liu F, Gong CX (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3, 8.
17. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR (2006) NFAT dysreg-ulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600.
18. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D, Feske S, Hogan PG, Rao A (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441, 646-650.
19. Liu F, Liang Z, Wegiel J, Hwang YW, Iqbal K, Grundke-Iqbal I, Ramakrishna N, Gong CX (2008) Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 22, 3224-3233.
20. Shi J, Zhang T, Zhou C, Chohan MO, Gu X, Wegiel J, Zhou J, Hwang YW, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F (2008) Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J Biol Chem 283, 28660-28669.
21. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17, 278-282.
22. Liu F, Li B, Tung EJ, Grundke-Iqbal I, Iqbal K, Gong CX (2007) Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur J Neurosci 26, 3429-3436.
23. Qian W, Liang H, Shi J, Jin N, Grundke-Iqbal I, Iqbal K, Gong CX, Liu F (2011) Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res 39, 6161-6171.
24. Pei JJ, Gong CX, Iqbal K, Grundke-Iqbal I, Wu QL, Win-bladB, Cowburn RF (1998) Subcellular distributionofprotein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J Neural Transm 105, 69-83.
25. Galceran J, de Graaf K, Tejedor FJ, Becker W (2003) The MNB/DYRK1A protein kinase: Genetic and biochemical properties. J Neural Transm Suppl, 139-148.
26. Kentrup H, Becker W, Heukelbach J, Wilmes A, Schurmann A, Huppertz C, Kainulainen H, Joost HG (1996) Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem 271, 3488-3495.
27. Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, Joost HG (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273, 25893-25902.
28. Becker W, Joost HG (1999) Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol 62, 1-17.
29. Himpel S, Tegge W, Frank R, Leder S, Joost HG, Becker W (2000) Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem 275, 2431-2438.
30. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7, 656-664.
31. Wang JZ, Liu F (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
32. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sak-aguchi G, Kato A, Hattori H, Uema T, Takeda M (2007) The DYRK1A gene, encoded inchromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16, 15-23.
33. Yin X, Jin N, Gu J, Shi J, Zhou J, Gong CX, Iqbal K, Grundke-Iqbal I, Liu F (2012) Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion. J Biol Chem 287, 30497-30506.
34. Andreadis A, Wagner BK, Broderick JA, Kosik KS (1996) A tau promoter region without neuronal specificity. J Neu-rochem 66, 2257-2263.
35. Maenz B, Hekerman P, Vela EM, Galceran J, Becker W (2008) Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1. BMC Mol Biol 9, 30.
36. Wang L, Brown SJ (2006) BindN: A web-based tool for efficient prediction of DNA and RNA binding sites in amino acid sequences. Nucleic Acids Res 34, W243-W248.
37. Sanford JR, Gray NK, Beckmann K, Caceres JF (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18, 755-768.
38. Caceres JF, Screaton GR, Krainer AR (1998) Aspecific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12, 55-66.